Interstitial Lung Disease & Idiopathic Pulmonary Fibrosis Lineup at ATS 2024

The ATS 2024 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in bronchiectasis and COPD, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the conference website. For more information on these and other sessions to be presented May 17–22 in San Diego, visit the online Advance Program.

  • A84. Combined Pulmonary Fibrosis and Emphysema: From Pathogenesis to Diagnosis and Therapeutic Implications
  • B82. Screening and Early Diagnosis of ILD in Patients with Connective Tissue Disease
  • B83. Artificial Intelligence in the Radiological Assessment of Interstitial Lung Disease
  • C81. Current and Evolving Strategies for Management of Pulmonary Sarcoidosis
  • C82. Pro/Con Debate on Progressive Pulmonary Fibrosis: Improving Understanding of a Disease Phenotype
  • C83. Pro/Con: Hot topics in Interstitial Lung Disease
  • C85. ATS Documents: Advancing Science and Improving Clinical Practice
  • D3. Interstitial Lung Abnormalities: Moving the Needle Towards Therapeutic Clinical Trials
  • D4. Lymphangioleiomyomatosis: At the Forefront of Scientific and Clinical Progress
  • D6. What Causes Sarcoidosis
  • D82. Who, What, Where, Why, How? Inhalational Exposures and ILD


Register today for the ATS 2024 International Conference! Don’t miss this opportunity to take part in the in-person conference, May 17-22 in San Diego. Join your colleagues to learn about the latest developments in pulmonary, critical care, and sleep medicine.

Not an ATS member? Join today and save up to $540.